Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “B-Cell Non-Hodgkin's Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07517705
What this trial is testing

MRD-Adapted Low-Dose Radiation Therapy During Frontline Chemoimmunotherapy for Diffuse Large B-Cell Lymphoma

Who this might be right for
Diffuse Large B-Cell Lymphoma
University of Nebraska 50
Testing effectiveness (Phase 2)Study completedNCT02890602
What this trial is testing

Erythropoietin for Management of Anemia Caused by Chemotherapy

Who this might be right for
Diffuse Large B-cell Lymphoma
Kosin University Gospel Hospital 53
Not applicableActive Not RecruitingNCT07310745
What this trial is testing

Low Dose Radiotherapy in Primary Indolent Cutaneous B-cell Lymphoma

Who this might be right for
Primary Indolent Cutaneous B-cell Lymphoma
Azienda USL Reggio Emilia - IRCCS 52
Testing effectiveness (Phase 2)Study completedNCT02853370
What this trial is testing

Bendamustine and Rituximab for the Treatment of Splenic Marginal Zone Lymphoma

Who this might be right for
Marginal Zone B-cell Lymphoma
International Extranodal Lymphoma Study Group (IELSG) 78
Early research (Phase 1)Study completedNCT00944905
What this trial is testing

Study of MDX-1203 in Subjects With Advanced/Recurrent Clear Cell Renal Cell Carcinoma (ccRCC) or Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (B-NHL)

Who this might be right for
Renal Cell CarcinomaNon-hodgkin's Lymphoma
Bristol-Myers Squibb 46
Large-scale testing (Phase 3)Looking for participantsNCT07011056
What this trial is testing

A Phase III Clinical Study of Purinostat Mesylate for Injection in Patients With Diffuse Large B-cell Lymphoma

Who this might be right for
Recurrent and Refractory Diffuse Large B-cell Lymphoma
Chengdu Zenitar Biomedical Technology Co., Ltd 390
Post-approval studies (Phase 4)Not Yet RecruitingNCT06956092
What this trial is testing

Glofitamab for Consolidation After First-line Treatment of High-risk Large B-cell Lymphoma

Who this might be right for
B Cell Lymphoma (BCL)
Zhengzhou University 40
Not applicableNot Yet RecruitingNCT07463781
What this trial is testing

Neurocognitive Assessment in Adults Undergoing CD19 Targeted CAR-T Cell Therapy

Who this might be right for
Diffuse Large B Cell Lymphoma (DLBCL)High Grade B Cell LymphomaPrimary Mediastinal B-cell Lymphoma (PMBCL)
Fondazione Italiana Linfomi - ETS 100
Early research (Phase 1)Study completedNCT00347971
What this trial is testing

Study of Recombinant Interleukin 21 in Combination With Rituxan for Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma, Non-Hodgkin
ZymoGenetics 23
Early research (Phase 1)Ended earlyNCT06028373
What this trial is testing

ATG-031 in Advanced Solid Tumors or B-cell Non-Hodgkin Lymphomas

Who this might be right for
Advanced Solid TumorsB-cell Non-Hodgkin Lymphomas
Antengene Biologics Limited 38
Early research (Phase 1)Ended earlyNCT01769222
What this trial is testing

Ipilimumab and Local Radiation for Selected Solid Tumors

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+31 more
Stanford University 3
Testing effectiveness (Phase 2)Looking for participantsNCT07283822
What this trial is testing

Amping up With PemJAK

Who this might be right for
Non-Hodgkin LymphomaHodgkin Disease LymphomaNon-Hodgkin Lymphoma Refractory/ Relapsed+5 more
Seda S. Tolu 53
Testing effectiveness (Phase 2)Study completedNCT00875056
What this trial is testing

Study of Vorinostat (MK-0683) With Follicular Lymphoma (FL), Other Indolent B-cell Non-Hodgkin's Lymphoma (B-NHL), or Mantle Cell Lymphoma (MCL) Participants (MK-0683-103)

Who this might be right for
Lymphoma
Merck Sharp & Dohme LLC 56
Testing effectiveness (Phase 2)Study completedNCT00002657
What this trial is testing

SWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ Transplant

Who this might be right for
LymphomaMultiple Myeloma and Plasma Cell Neoplasm
SWOG Cancer Research Network 20
Large-scale testing (Phase 3)Study completedNCT00052936
What this trial is testing

Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
German High-Grade Non-Hodgkin's Lymphoma Study Group 1,506
Testing effectiveness (Phase 2)Looking for participantsNCT04544592
What this trial is testing

UCD19 CarT in Treatment of Pediatric B-ALL and B-NHL

Who this might be right for
B-cell Acute Lymphoblastic LeukemiaB-cell Non Hodgkin Lymphoma
University of Colorado, Denver 45
Very early researchNot Yet RecruitingNCT07066436
What this trial is testing

ImmunoMRI for Assessment of Tumor-associated Macrophages

Who this might be right for
DLBCL - Diffuse Large B Cell Lymphoma
Medical University of Vienna 60
Not applicableStudy completedNCT02708732
What this trial is testing

Utility Study in Diffuse Large B-Cell Lymphoma (DLBCL)

Who this might be right for
Diffuse Large B-Cell Lymphoma
Hoffmann-La Roche 91
Testing effectiveness (Phase 2)Ended earlyNCT00788606
What this trial is testing

R-CHOP-B Bevacizumab for Diffuse Large B Cell Lymphoma

Who this might be right for
Non-Hodgkin's LymphomaB-cell Lymphoma
Royal Marsden NHS Foundation Trust 7
Early research (Phase 1)Study completedNCT02240719
What this trial is testing

Everolimus and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory Hematologic Cancer

Who this might be right for
Recurrent Adult Diffuse Large Cell LymphomaRecurrent Adult Hodgkin LymphomaRecurrent Grade 1 Follicular Lymphoma+5 more
University of California, Davis 20
Next Page